Results 261 to 270 of about 618,091 (376)
Comprehending toll-like receptors: pivotal element in the pathogenesis of sepsis and its complications. [PDF]
Wang W, Mu S, Yan D, Qin H, Zheng Z.
europepmc +1 more source
ABSTRACT To evaluate the prevalence of psychiatric signs and symptoms and describe psychotherapeutic and psychopharmacological interventions among children with osteogenesis imperfecta (OI). PRISMA guidelines were followed, and the study was registered in PROSPERO (CRD42024588284). Studies (n = 1419) were identified across five databases.
Julia M. Morales +13 more
wiley +1 more source
RNA Viruses, Toll-Like Receptors, and Cytokines: The Perfect Storm? [PDF]
Stegeman SK +7 more
europepmc +1 more source
Toll-like receptors in immunity and inflammatory diseases: Past, present, and future
K. Vijay
semanticscholar +1 more source
Examining the Impact of Domestic and Family Violence on Young Australians’ School‐Level Education
ABSTRACT Australian policy and practice increasingly acknowledges the need to respond to children as victim‐survivors of domestic and family violence (DFV) in their own right. As part of this, and in recognition that schools often have the most consistent contact with young people experiencing DFV, there is mounting recognition of the role education ...
Rebecca Stewart +2 more
wiley +1 more source
Involvement of nucleic acid-sensing toll-like receptors in human diseases and their controlling mechanisms. [PDF]
Lin YS +4 more
europepmc +1 more source
ABSTRACT In 2019, the Australian government established the Royal Commission into Violence, Abuse, Neglect and Exploitation of People with Disability (‘Disability Royal Commission’, DRC) to investigate widespread mistreatment of people with disability. Nearly 10,000 people with disability, their families and supporters engaged with the DRC.
Kate D'Cruz +7 more
wiley +1 more source
Targeting toll-like receptors: unveiling potential therapeutic strategies for deep vein thrombosis. [PDF]
Shao W, Wang Z, Wu J, Guo T, Mo J.
europepmc +1 more source
Application of a Toll-Like Receptor 7 Agonist in Immunotherapy of Type 1 Diabetes /
Caroline Sheng
openalex +1 more source

